Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin-Dependent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01299844
What this trial is testing

Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
University of Connecticut 208
Very early researchStudy completedNCT01414556
What this trial is testing

GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Mikkel Christensen 12
Not applicableStudy completedNCT00738153
What this trial is testing

An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 798
Not applicableUnknownNCT02212522
What this trial is testing

Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications

Who this might be right for
Diabetes MellitusInsulin-Dependent
Assistance Publique - Hôpitaux de Paris 20,000
Not applicableStudy completedNCT00774488
What this trial is testing

Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose Tissue

Who this might be right for
Metabolic SyndromeObesityInsulin Sensitivity
German Institute of Human Nutrition 17
Large-scale testing (Phase 3)Study completedNCT00115570
What this trial is testing

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Sanofi 572
Testing effectiveness (Phase 2)Study completedNCT00044694
What this trial is testing

Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
AstraZeneca 156
Not applicableStudy completedNCT04646980
What this trial is testing

Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses

Who this might be right for
Influenza-like Illness
Zagazig University 80
Not applicableStudy completedNCT02158741
What this trial is testing

Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNIDDMNon-insulin Dependent Diabetes Mellitus
McMaster University 291
Large-scale testing (Phase 3)UnknownNCT03562208
What this trial is testing

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Who this might be right for
Diabetes Mellitus ProgressionDiabetes Complications
Global Cell Med 100
Early research (Phase 1)Not Yet RecruitingNCT06934616
What this trial is testing

A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors

Who this might be right for
Solid Tumor Cancer
Genor Biopharma Co., Ltd. 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808151
What this trial is testing

Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

Who this might be right for
Colon CancerMicrosatellite Stable (MSS) Colon CancerProficient Mismatch Repair (pMMR) Colon Cancer
Solstice Oncology, Inc. 100
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Not applicableStudy completedNCT01274052
What this trial is testing

Study of Postprandial Incretin Response in Women With Gestational Diabetes

Who this might be right for
Gestational Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 19
Post-approval studies (Phase 4)Ended earlyNCT01582282
What this trial is testing

Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects

Who this might be right for
Non-Insulin-dependent Diabetes Mellitus
Procter and Gamble 37
Not applicableStudy completedNCT00006160
What this trial is testing

African-American Diabetes Intervention Project

Who this might be right for
Insulin-Dependent Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing

A Personalized Cancer Vaccine Targeting Shared Neoantigens

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39
Not applicableStudy completedNCT01580813
What this trial is testing

Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 13
Not applicableStudy completedNCT04253080
What this trial is testing

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Who this might be right for
Cutaneous Melanoma
Assistance Publique - Hôpitaux de Paris 127
Not applicableUnknownNCT02425410
What this trial is testing

Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset

Who this might be right for
Diabetes MellitusInsulin-Dependent
Assistance Publique - Hôpitaux de Paris 2,000
Next Page